Human IL6ST (CD130/gp130) knockout A549 cell lysate (ab257207)
Properties
-
Storage instructions
Store at -80°C. Please refer to protocols. -
Components 1 kit ab262026 - Human IL6ST knockout A549 cell lysate 1 x 100µg ab255554 - Human wild-type A549 cell lysate 1 x 100µg -
Research areas
-
Cell type
epithelial -
Disease
Carcinoma -
STR Analysis
Amelogenin X,Y D5S818: 11 D13S317: 11 D7S820: 8, 11 D16S539: 11, 12 vWA: 14 TH01: 8,9.3 TPOX: 8,11 CSF1PO: 10, 12
Images
-
Western blot - Human IL6ST knockout A549 cell lysate (ab257207)
Lane 1: Wild-type A549 cell lysate (20 µg)
Lane 2: IL6ST knockout A549 cell lysate (20 µg)
Lanes 1-2: Merged signal (red and green). Green - ab217671 observed at 130 kDa. Red - loading control ab7291 observed at 50 kDa.
ab217671 Anti-CD130 (gp130) antibody [EPR21732] was shown to specifically react with CD130 (gp130) in wild-type A549 cells. Loss of signal was observed when knockout cell line ab266938 (knockout cell lysate ab257207) was used. Wild-type and CD130 (gp130) knockout samples were subjected to SDS-PAGE. ab217671 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
-
Sanger Sequencing - Human IL6ST knockout A549 cell lysate (ab257207)Allele-1: 4 bp deletion in exon4
-
Sanger Sequencing - Human IL6ST knockout A549 cell lysate (ab257207)Allele-2: 1 bp insertion in exon4